Before accessing the site, please choose from the following options.
Executive Director | 11 years industry experience
Executive Director 11 years industry experience
Anne Edelstein is an investor for Counterpoint Global. She joined Morgan Stanley in 2018 and has 11 years of investment experience. Prior to joining the firm, she was a Vice President and Equity Research Analyst at Bank of America Merrill Lynch (BAML) following life science tools and diagnostics. She previously covered semiconductors and specialty pharmaceuticals, also for BAML. Anne earned a B.A. in neuroscience at Hamilton College.
The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.
All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.
Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.